thirty-four of the 39 patients with short-duration response to l-dopa experienced a consistent and reproducible sequence of clinical and biochemical events after each dose , characterized by improvement of parkinsonism and a single phase of dystonia occurring during or shortly after the peak of dopa concentration in plasma and during maximal clinical improvement .
C0023570
l-dopa
C0013023
dopa